Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Uber Q4 and Full Year 2025 Earnings Call - AVs as growth lever, huge free cash flow, and aggressive buybacks
Uber closed 2025 with accelerating demand and hefty cash generation. Trips reached a 15 billion annual run rate, monthly actives topped 200 million, and gross bookings grew 22% year over year. Managem...
- Trips accelerated to a 15 billion annual run rate, signaling sustained demand growth across the platform.
- Monthly active users topped 200 million, and annual active base exceeds 450 million, with MAPC growth stepping up from ~14% to ~18% year over year in 2025.
- Gross bookings rose 22% year over year for Q4/2025, and Uber delivered its fifth consecutive year of annual gross bookings over 20%.
- +14 more takeaways
Aurora Cannabis Q3 2026 Earnings Call - Pivot to Global Medical Cannabis; Exiting Select Canadian Consumer Markets and Divesting Bevo
Aurora reported a solid fiscal Q3 2026 led by its global medical cannabis business, which drove revenue growth, high margins, and positive free cash flow. Management doubled down on that strategy, ann...
- Aurora is pivoting decisively to global medical cannabis, reallocating products and resources away from select lower-margin Canadian consumer cannabis markets.
- Net revenue for fiscal Q3 2026 was CAD 94.2 million, up 7% year over year; global medical cannabis revenue was CAD 76.2 million, up 12% and 81% of total revenue.
- Adjusted gross margin improved 100 basis points to 62% overall, with global medical cannabis delivering a 69% adjusted gross margin and accounting for roughly 95% of adjusted gross profit.
- +14 more takeaways
T. Rowe Price Q4 2025 Earnings Call - Market Gains Mask $56.9B Net Outflows and a Lower-Fee Mix
T. Rowe Price closed 2025 with $1.78 trillion in AUM, helped more by a third straight year of strong market returns than by net new money. The company reported $56.9 billion of net outflows for the ye...
- AUM rose to $1.78 trillion at year-end 2025, up more than 10% from the start of the year, driven largely by market appreciation rather than net inflows.
- T. Rowe Price reported $56.9 billion of net outflows for full-year 2025, with $25.5 billion of those outflows occurring in Q4.
- Outflows were concentrated in equity strategies, with $75 billion of equity net outflows in 2025, and almost $64 billion leaving mutual funds on a vehicle basis.
- +13 more takeaways
Enact Q4 2025 Earnings Call - Board Authorizes Largest Buyback as Credit Improves and $500M Capital Return Target Set for 2026
Enact closed 2025 with a strong quarter, reporting adjusted operating income of $179 million in Q4 and $688 million for the year, while raising book value per share 11% to $37.87. Management highlight...
- Board approved new $500 million share repurchase program, largest in company history, and management expects ~ $500 million of capital returns for 2026.
- Q4 adjusted operating income was $179 million, or $1.23 per diluted share; full-year adjusted operating income was $688 million, or $4.61 per diluted share.
- Net reserve release of $60 million in Q4, driven by strong cure performance, loss mitigation, and reducing the assumed claim rate from 9% to 8%.
- +12 more takeaways
Novo Nordisk Q4 2025 Earnings Call - Wegovy pill surges, but 2026 guidance warns price-driven sales decline
Novo reported solid 2025 results, with sales up 10% and operating profit up 6% at constant exchange rates, driven by runaway growth in obesity care and a steady GLP-1 franchise. The headline story is ...
- 2025 results: sales +10% and operating profit +6% at constant exchange rates, gross margin fell to 81% from 84.7% due to amortization and restructuring effects.
- Obesity care exploded, from DKK 6bn in 2019 to DKK 82bn in 2025, with Wegovy sales at DKK 28bn, up 134% in 2025.
- Wegovy pill approved by FDA December 22, launched January 5, and early uptake is rapid: about 50,000 prescriptions for the week ending January 23, with roughly 45,000 through self-pay that week.
- +13 more takeaways
Amcor Fiscal 2026 Q2 Earnings Call - Synergies Accelerate, Core Outperforms While Non-core Lags
Amcor reported an in-line Fiscal 2026 Q2, showing the early payoff from the Berry acquisition while flagging clear unevenness across the combined portfolio. Management posted $5.4 billion in revenue, ...
- Q2 headline numbers: revenue $5.4 billion, EBITDA $826 million, EBIT $603 million.
- Adjusted EPS was $0.86 for Q2, up 7% year over year, and up 14% for the first half.
- Management reaffirmed full-year adjusted EPS guidance of $4.00 to $4.15 per share, reflecting a 1-for-5 reverse stock split.
- +12 more takeaways
Chipotle Mexican Grill Q4 2025 Earnings Call - Reinvesting for Transaction Growth While Margins Face Near-Term Pressure
Chipotle reported a year of resilience and investment, with 2025 revenue up 5.4% and adjusted diluted EPS rising 4.5% to $1.17, even as comps slipped. Management is leaning hard into a multi-pronged g...
- 2025 results mixed: revenue grew 5.4% year over year, adjusted diluted EPS rose 4.5% to $1.17, while full-year comparable sales declined 1.7%.
- Q4 specifics: sales were $3.0 billion, comp sales down 2.5% for the quarter, and adjusted diluted EPS for Q4 was $0.25, flat year over year.
- Gift card accounting boosted Q4 sales by $27 million and provided about a 70 basis point benefit to restaurant-level margin, a one-time accounting effect that did not affect comps.
- +12 more takeaways
Enphase Energy Q4 2025 Earnings Call - Margin Resilience and a Big Product Bet to Offset a 5% Tariff Hit
Enphase closed Q4 2025 with $343.3 million in revenue, strong non-GAAP margins and a strategic pivot toward product-led volume to blunt a roughly 5% reciprocal tariff headwind. Management says Q1 2026...
- Q4 revenue $343.3 million, with non-GAAP gross margin 46.1% and GAAP gross margin 44.3%; non-GAAP operating income about 23% of revenue.
- Company reported roughly 1.3 million domestically produced microinverters shipped from Texas and South Carolina in Q4, booking Section 45X production tax credits.
- IQ batteries shipments: 150.1 MWh reported for the quarter, including 51.1 MWh of IQ batteries made in Texas to meet domestic content rules.
- +16 more takeaways
The Clorox Company Q2 FY2026 Earnings Call - ERP completion clears path for back-half innovation and margin recovery
Clorox says the messy part of its multi-quarter ERP rollout is behind it, and management expects ERP-related shipment timing noise to reverse in Q3, clearing the runway for a heavy slate of back-half ...
- ERP implementation: the final manufacturing phase went live in January, creating higher-than-expected retailer prebuilds that produced roughly 1 point of shipment favorability in Q2 and is expected to reverse in Q3.
- Timing pickup to FY27: management said the ERP shipment timing normalization should translate into about a 3.5 point sales pickup and roughly $0.90 of EPS benefit in fiscal 2027 relative to fiscal 2026.
- One-time digital adjustments: management expects a final ERP/digital investment adjustment in Q3, roughly $0.08 of impact, and no further one-time ERP P&L adjustments after that quarter.
- +12 more takeaways
Intapp Q2 FY2026 Earnings Call - Cloud ARR Up 31%, AI and Microsoft Partnerships Powering Enterprise Migrations
Intapp posted another quarter of cloud-first momentum. Cloud ARR rose 31% year-over-year to $433.6 million, pushing cloud to 81% of total ARR. SaaS revenue was $102.5 million, total revenue $140.2 mil...
- Cloud ARR reached $433.6 million, up 31% year-over-year, and now represents about 81% of total ARR ($535 million).
- SaaS revenue was $102.5 million, up 28% year-over-year; total revenue was $140.2 million, up 16% year-over-year.
- Non-GAAP gross margin improved to 78.1% from 76.7% a year ago, driven by favorable mix and cloud efficiency gains.
- +13 more takeaways